MedTrace Logo

Effectiveness of Smartconsent in Improving Understanding of Informed Consent

NCT04856943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-07-18

No results posted yet for this study

Summary

The general objective of the study is to assess whether the new smartconsent tool improves patients' understanding of the intervention to be performed, compared to standard practice.

A randomized clinical trial will be conducted in 50 patients who will undergo LASER PROSTATIC ENUCLEATION.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

Smartconsent application

Patients asigned to smartconsent group will sign informed consent through a Tablet.

OTHER

Control group

Patient asigned to control group will sing the informed consent in papel, as it is performed in clinical practice

Sponsors & Collaborators

  • Bioaraba Health Research Institute

    lead NETWORK

Principal Investigators

  • IMANOL MERINO · Bioaraba Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04856943 on ClinicalTrials.gov